| 000 | 01829 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516083445.0 | ||
| 264 | 0 | _c20120921 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1740-634X | ||
| 024 | 7 |
_a10.1038/npp.2012.24 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBehan, Aine T | |
| 245 | 0 | 0 |
_aChronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cJun 2012 |
||
| 300 |
_a1773-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCannabinoid Receptor Modulators _xmetabolism |
| 650 | 0 | 4 |
_aCatechol O-Methyltransferase _xgenetics |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
| 650 | 0 | 4 |
_aDronabinol _xpharmacology |
| 650 | 0 | 4 | _aEndocannabinoids |
| 650 | 0 | 4 |
_aGABAergic Neurons _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aHryniewiecka, Magdalena | |
| 700 | 1 | _aO'Tuathaigh, Colm M P | |
| 700 | 1 | _aKinsella, Anthony | |
| 700 | 1 | _aCannon, Mary | |
| 700 | 1 | _aKarayiorgou, Maria | |
| 700 | 1 | _aGogos, Joseph A | |
| 700 | 1 | _aWaddington, John L | |
| 700 | 1 | _aCotter, David R | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 37 _gno. 7 _gp. 1773-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/npp.2012.24 _zAvailable from publisher's website |
| 999 |
_c21638336 _d21638336 |
||